China Pharma Prices Registered Direct Offering Of 2.5M Shares At $2.00 Per Share
Benzinga Newsdesk 3 months ago
OfferingsNews
The gross proceeds from the offering will be $5 million, before deducting placement agent fees and other offering expenses.The Company intends to use the net proceeds from this offering for working capital and general
The gross proceeds from the offering will be $5 million, before deducting placement agent fees and other offering expenses.
The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
The offering is expected to be closed on or about July 23, 2026.